Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
A peer-reviewed journal published by the National Center for Infectious Diseases
Emerging Infectious Diseases
Navigation Bar

Suggested Citation


Perspectives

The Cost Effectiveness of Vaccinating against Lyme Disease

Martin I. Meltzer, David T. Dennis, and Kathleen A. Orloski
Centers for Disease Control and Prevention, Atlanta, Georgia, USA


melt1b.gif (19117 bytes)
Back to article

Figure 1: Decision tree to model the cost effectiveness of vaccinating a person against Lyme disease.


melt2b.gif (11775 bytes)
Back to article

Figure 2: Average cost effectiveness of vaccinating a person against Lyme disease with changes in the cost of vaccination, probabilities of identifying and treating early Lyme disease, and probabilities of contracting Lyme disease. A negative value indicates that vaccinating a person will result in a net cost to society, while a positive value indicates a net savings to society. The results shown are the means from Monte Carlo simulations (see Table 1 and text for further details). Vaccine assumed 85% effective (Table 1).

 

Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed July 1, 1999

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention


Contact Us EID Search Past Issues Upcoming Issues Expedited Current Issue EID Home